Livongo Studies Demonstrate Latest Technology, Coaching, and Real-Time Data Improve Blood Glucose Control for People with Diabetes
Online, June 13, 2016 (Newswire.com) - MOUNTAIN VIEW, Calif.--Livongo Health, the leading consumer digital health company focused on improving care of chronic conditions, has unveiled two studies that demonstrate that a cellular enabled blood glucose device offering individualized recommendations and personalized coaching sessions improve glycemic control for people with diabetes. The studies were presented at the 76th Annual American Diabetes Association Scientific Sessions in New Orleans, La.
"These studies are significant because they demonstrate the clinical improvement in a measure that is universally agreed upon as a key factor in diabetes management."
As part of its research, Livongo studied more than 10,000 individuals between October 2014 and March 2016. Results of the studies indicate that individuals using the Livongo for Diabetes program report improved and sustained blood glucose control with 0.7% reduction in HbA1c and sustained glycemic control with 33mg/dL reduction in average blood glucose values up to one year accompanied by a 15% average decrease in likelihood of a day with hypoglycemia (BG